Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1711-1726
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1711
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1711
Figure 1 Histograms and density graphs description comparisons of the original, propensity score match and inverse probability of treatment weighting distributions in the consolidation chemotherapy and non-consolidation chemotherapy groups.
PSM: Propensity score match; IPTW: Inverse probability of treatment weighting; CC: Consolidation chemotherapy.
- Citation: Sheng XQ, Wang HZ, Li S, Zhang YZ, Geng JH, Zhu XG, Quan JZ, Li YH, Cai Y, Wang WH. Consolidation chemotherapy with capecitabine after neoadjuvant chemoradiotherapy in high-risk patients with locally advanced rectal cancer: Propensity score study. World J Gastrointest Oncol 2022; 14(9): 1711-1726
- URL: https://www.wjgnet.com/1948-5204/full/v14/i9/1711.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i9.1711